United Therapeutics (UTHR) Interest Coverage Ratio Growth (1y) (2010 - 2026)
United Therapeutics (UTHR) Interest Coverage Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.70 Bn | 30.76 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 27.73 Bn | 23.67 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | -58.34% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.18 Bn | 18.37 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -14.91% |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | -86.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.34% |
| Dec 31, 2025 | 67.27% |
| Sep 30, 2025 | -0.38% |
| Jun 30, 2025 | 61.82% |
| Mar 31, 2025 | -32.31% |
| Dec 31, 2024 | 299.35% |
| Sep 30, 2024 | -51.71% |
| Jun 30, 2024 | -47.58% |
| Mar 31, 2024 | 32.30% |
| Dec 31, 2023 | 20.65% |
| Sep 30, 2023 | 7.47% |
| Jun 30, 2023 | 124.11% |
| Mar 31, 2023 | -34.40% |
| Dec 31, 2022 | -60.48% |
| Sep 30, 2022 | 2.27% |
| Jun 30, 2022 | -52.98% |
| Mar 31, 2022 | 461.47% |
| Dec 31, 2021 | 281.75% |
| Sep 30, 2021 | -98.82% |
| Jun 30, 2021 | -86.58% |